AIM London Stock Exchange query on Share Price Movement
The Directors of THR have noted that the pricing of the Company quoted securities on The Australian Securities Exchange, and the Alternative Investment Market of the London Stock Exchange("AIM"), has risen in the past few days and offer that either or both of the following factors may have influenced the price and volume of the THR securities:-
* The current high market price for gold and;
* The recently announced commencement of drilling at the Dundas Gold Project, in the Albany Fraser Belt near Norseman, in Western Australia
* The announcement in January of an agreement to acquire an interest in the Spring Hill Gold Project near Creek in the Northern Territory
* The continued strengthening of the quoted international price for tungsten (Reference Metal Pages.com) and its potential for a positive impact on the economics of the Molyhil Molybdenum/Tungsten project in Northern Territory.
- Forums
- ASX - By Stock
- aim share price movement query
THR
thor energy plc
Add to My Watchlist
0.00%
!
0.9¢

AIM London Stock Exchange query on Share Price MovementThe...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.397M |
Open | High | Low | Value | Volume |
0.9¢ | 1.1¢ | 0.9¢ | $4.757K | 497.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 1387728 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 1387728 | 0.009 |
8 | 1646833 | 0.008 |
6 | 1643979 | 0.007 |
4 | 1006832 | 0.006 |
2 | 577727 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 100000 | 1 |
0.012 | 993871 | 4 |
0.014 | 255000 | 1 |
0.015 | 243352 | 1 |
0.016 | 100000 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
THR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online